Midgard Science

Labs / Assays & in vitro testing

SEED Therapeutics

Prussia, PA, United States · seedtherapeutics.com

On your own

Free. Their own form.

Contact SEED Therapeutics directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

SEED Therapeutics develops de novo molecular glue degraders for disease targets that are difficult to address with traditional therapies. It focuses on oncology, neurodegeneration, and immunology, with work centered in King of Prussia, Pennsylvania.

Their website has a general contact form; we send your quote request through it.

What they offer

  • Molecular glue degrader discovery

    Designs de novo molecular glues to recruit E3 ligases and eliminate disease-causing proteins.

  • Targeted protein degradation platform development

    Uses the RITE3™ platform to identify ligase-target pairs and advance degradation programs.

  • Preclinical degrader program development

    Advances degrader programs through target selection, lead identification, and IND candidate stages.

  • Clinical-stage program development

    Advances selected degrader programs into Phase 1 clinical trials.

What they work on

Modalities
Small molecule, Peptide
Species and models
xenograft models
Assays and studies
high-throughput screening, live-cell assays, proteomics, structural biology, molecular modeling
Instruments and platforms
LumID
Therapeutic areas
oncology, neurodegeneration, immunology
Sites
King of Prussia, USA
Address
411 Swedeland Rd, Suite 1000, King of Prussia, PA, 19406

Similar labs. Mirimus, Sai Life, AssayQuant, Aurigene Pharmaceutical Services

Found in a contract services directory. Listing built from seedtherapeutics.com. Work here? Claim this listing.

SEED Therapeutics · Midgard Science